Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

17 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Randomized controlled trials in de-implementation research: a systematic scoping review.
Raudasoja AJ, Falkenbach P, Vernooij RWM, Mustonen JMJ, Agarwal A, Aoki Y, Blanker MH, Cartwright R, Garcia-Perdomo HA, Kilpeläinen TP, Lainiala O, Lamberg T, Nevalainen OPO, Raittio E, Richard PO, Violette PD, Komulainen J, Sipilä R, Tikkinen KAO. Raudasoja AJ, et al. Among authors: nevalainen opo. Implement Sci. 2022 Oct 1;17(1):65. doi: 10.1186/s13012-022-01238-z. Implement Sci. 2022. PMID: 36183140 Free PMC article.
Effect of remdesivir post hospitalization for COVID-19 infection from the randomized SOLIDARITY Finland trial.
Nevalainen OPO, Horstia S, Laakkonen S, Rutanen J, Mustonen JMJ, Kalliala IEJ, Ansakorpi H, Kreivi HR, Kuutti P, Paajanen J, Parkkila S, Paukkeri EL, Perola M, Pourjamal N, Renner A, Rosberg T, Rutanen T, Savolainen J; Solidarity Finland Investigators; Haukka JK, Guyatt GH, Tikkinen KAO. Nevalainen OPO, et al. Nat Commun. 2022 Oct 18;13(1):6152. doi: 10.1038/s41467-022-33825-5. Nat Commun. 2022. PMID: 36257950 Free PMC article.
Effects of remdesivir in patients hospitalised with COVID-19: a systematic review and individual patient data meta-analysis of randomised controlled trials.
Amstutz A, Speich B, Mentré F, Rueegg CS, Belhadi D, Assoumou L, Burdet C, Murthy S, Dodd LE, Wang Y, Tikkinen KAO, Ader F, Hites M, Bouscambert M, Trabaud MA, Fralick M, Lee TC, Pinto R, Barratt-Due A, Lund-Johansen F, Müller F, Nevalainen OPO, Cao B, Bonnett T, Griessbach A, Taji Heravi A, Schönenberger C, Janiaud P, Werlen L, Aghlmandi S, Schandelmaier S, Yazdanpanah Y, Costagliola D, Olsen IC, Briel M. Amstutz A, et al. Among authors: nevalainen opo. Lancet Respir Med. 2023 May;11(5):453-464. doi: 10.1016/S2213-2600(22)00528-8. Epub 2023 Feb 21. Lancet Respir Med. 2023. PMID: 36828006 Free PMC article.
Reporting of costs and economic impacts in randomized trials of de-implementation interventions for low-value care: a systematic scoping review.
Falkenbach P, Raudasoja AJ, Vernooij RWM, Mustonen JMJ, Agarwal A, Aoki Y, Blanker MH, Cartwright R, Garcia-Perdomo HA, Kilpeläinen TP, Lainiala O, Lamberg T, Nevalainen OPO, Raittio E, Richard PO, Violette PD, Tikkinen KAO, Sipilä R, Turpeinen M, Komulainen J. Falkenbach P, et al. Among authors: nevalainen opo. Implement Sci. 2023 Aug 21;18(1):36. doi: 10.1186/s13012-023-01290-3. Implement Sci. 2023. PMID: 37605243 Free PMC article. Review.
Short- and long-term effects of imatinib in hospitalized COVID-19 patients: A randomized trial.
Halme ALE, Laakkonen S, Rutanen J, Nevalainen OPO, Sinisalo M, Horstia S, Mustonen JMJ, Pourjamal N, Vanhanen A; Solidarity Finland Investigators; Rosberg T, Renner A, Perola M, Paukkeri EL, Patovirta RL, Parkkila S, Paajanen J, Nykänen T, Mäntylä J, Myllärniemi M, Mattila T, Leinonen MK, Külmäsu A, Kuutti P, Kuitunen I, Kreivi HR, Kilpeläinen TP, Kauma H, Kalliala IEJ, Järvinen P, Hankkio R, Hammarén T, Feuth T, Ansakorpi H, Ala-Karvia R, Guyatt GH, Tikkinen KAO. Halme ALE, et al. Among authors: nevalainen opo. J Infect. 2024 Sep;89(3):106217. doi: 10.1016/j.jinf.2024.106217. Epub 2024 Jul 3. J Infect. 2024. PMID: 38969238 Free article. Clinical Trial.
17 results